Table 3.
Univariate Cox regression analysis of survival.
| Variables | Univariate analysis | P |
|---|---|---|
| HR (95% CI) | ||
| Sex (female vs. male) | 0.901 (0.583-1.391) | 0.638 |
| Age (<70 years vs. ≥70 years) | 1.203 (0.839-1.724) | 0.315 |
| Tumor volume (<5 cm³ vs. ≥5 cm³) | 1.829 (1.267-2.640) | 0.001 |
| Tumor differentiation (well, moderate vs. poor) | 1.030 (0.745-1.424) | 0.859 |
| Tumor stage (0, 1, 2, 3 vs. 4) | 2.062 (1.661-2.560) | <0.001 |
| Tumor depth (T1, T2, T3 vs. T4) | 1.737 (1.383-2.181) | <0.001 |
| Lymph node involvement (N0, N1, N2 vs. N3) | 1.797 (1.527-2.115) | <0.001 |
| Metastasis (M0 vs. M1) | 2.118 (1.278-3.509) | 0.004 |
| CD155 (low vs. high) | 1.476 (1.027-2.121) | 0.035 |
| CD155/CD3 (others vs. high/low) | 1.643 (1.134-2.380) | 0.009 |
| CD155/CD4 (others vs. high/low) | 1.863 (1.295-2.679) | 0.001 |
| CD155/CD8 (others vs. high/low) | 1.788 (1.247-2.562) | 0.002 |
| CD155/Foxp3 (others vs. high/low) | 1.425 (0.986-2.060) | 0.060 |
| CD155/IL-17 (others vs. high/low) | 1.465 (1.021-2.101) | 0.038 |
| CD155/IFN-γ (others vs. high/low) | 1.831 (1.253-2.674) | 0.002 |
| CD155/CD19 (others vs. high/low) | 2.145 (1.486-3.095) | <0.001 |
| CD155/CD11c (others vs. high/low) | 1.390 (0.951-2.033) | 0.089 |
| CD155/CD56 (others vs. high/low) | 1.425 (0.996-2.040) | 0.053 |
| CD155/CD68 (others vs. high/low) | 1.262 (0.861-1.849) | 0.234 |
| CD155/CD31 (others vs. high/low) | 1.176 (0.788-1.756) | 0.427 |
| CD155/α-SMA (others vs. high/low) | 1.716 (1.178-2.500) | 0.005 |